ANGELA MORALES: Open Payments
NPI 1376574962 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,682 in 80 payments from 20 companies in 2025. Trend: 2023 $632 · 2024 $1,769 · 2025 $1,682
Food & beverage: $1,682
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $280 |
| Novo Nordisk Inc | 11 | $234 |
| Lilly USA, LLC | 6 | $202 |
| AstraZeneca Pharmaceuticals LP | 4 | $143 |
| Amgen Inc. | 8 | $133 |
| Lundbeck LLC | 6 | $119 |
| Eisai Inc. | 3 | $92 |
| PFIZER INC. | 5 | $82 |
| Teva Pharmaceuticals USA, Inc. | 3 | $73 |
| Novartis Pharmaceuticals Corporation | 3 | $65 |
Products named: ZEPBOUND, VRAYLAR, VYEPTI, Ozempic, AIRSUPRA, UBRELVY, Leqembi, OTEZLA.
Industry payments across FL — which companies pay providers there.
